Corinne Johnson
Stock Analyst at Goldman Sachs
(0.14)
# 4,124
Out of 4,820 analysts
7
Total ratings
16.67%
Success rate
-19.87%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corinne Johnson
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RNA Avidity Biosciences | Initiates: Buy | $59 | $31.21 | +89.04% | 1 | Sep 24, 2024 | |
| AVBP ArriVent BioPharma | Maintains: Buy | $28 → $38 | $20.92 | +81.64% | 2 | Sep 10, 2024 | |
| CGON CG Oncology | Upgrades: Buy | $43 → $50 | $27.97 | +78.76% | 3 | May 14, 2024 | |
| IMVT Immunovant | Initiates: Buy | $50 | $15.43 | +224.15% | 1 | Mar 13, 2024 |
Avidity Biosciences
Sep 24, 2024
Initiates: Buy
Price Target: $59
Current: $31.21
Upside: +89.04%
ArriVent BioPharma
Sep 10, 2024
Maintains: Buy
Price Target: $28 → $38
Current: $20.92
Upside: +81.64%
CG Oncology
May 14, 2024
Upgrades: Buy
Price Target: $43 → $50
Current: $27.97
Upside: +78.76%
Immunovant
Mar 13, 2024
Initiates: Buy
Price Target: $50
Current: $15.43
Upside: +224.15%